×
验证码:
换一张
忘记密码?
记住我
切换中国科技网通行证登录
×
切换中国科技网通行证登录
登录
中文版
|
English
中国科学院合肥物质科学研究院机构知识库
Knowledge Management System of Hefei Institute of Physical Science,CAS
登录
注册
ALL
ORCID
题名
作者
学科领域
关键词
文献类型
出处
收录类别
出版者
发表日期
存缴日期
资助项目
学科门类
学习讨论厅
图片搜索
粘贴图片网址
首页
研究单元&专题
作者
文献类型
学科分类
知识图谱
新闻&公告
在结果中检索
研究单元&专题
中科院强磁场科学中心 [5]
中科院合肥智能机械研... [3]
技术生物与农业工程研... [2]
中国科学院核能安全技... [2]
合肥创新院 [2]
应用技术研究所 [1]
更多...
作者
刘青松 [3]
石磊 [2]
张蕾 [2]
钟凯 [2]
张俊 [2]
王薇 [2]
更多...
发表日期
2022 [6]
2021 [8]
2019 [2]
2018 [3]
2017 [6]
2016 [4]
更多...
语种
英语 [29]
出处
ANNALS OF ... [4]
CANCER RES... [3]
JOURNAL OF... [3]
ACS NANO [2]
NUCLEAR SC... [2]
ACS APPLIE... [1]
更多...
资助项目
Zhejiang P... [2]
Zhejiang P... [2]
Zhejiang P... [2]
Beijing Mu... [1]
China Post... [1]
Health Bur... [1]
更多...
资助机构
National N... [4]
Chinese Ac... [2]
Zhejiang P... [2]
Zhejiang P... [2]
"Hundred T... [1]
11040606Q5... [1]
更多...
收录类别
SCI [30]
摘要
文献类型
期刊论文 [30]
×
知识图谱
HFCAS OpenIR
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共30条,第1-10条
帮助
限定条件
收录类别:SCI
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
题名升序
题名降序
期刊影响因子升序
期刊影响因子降序
发表日期升序
发表日期降序
WOS被引频次升序
WOS被引频次降序
提交时间升序
提交时间降序
作者升序
作者降序
The reversal of anti-HER2 resistance in advanced HER2-positive breast cancer using apatinib: two cases reports and literature review
期刊论文
TRANSLATIONAL CANCER RESEARCH, 2022
作者:
He, Libin
;
Shen, Xiabo
;
Liu, Yiyuan
;
Gao, Lu
;
Wu, Jiayi
;
Yu, Chang
;
Li, Guangliang
;
Wang, Xiaojia
;
Shao, Xiying
收藏
  |  
浏览/下载:41/0
  |  
提交时间:2022/12/23
Advanced human epidermal growth factor receptor 2-positive breast cancer (advanced HER2-positive breast cancer)
apatinib
case report
A prospective, open-label, multicenter phase IV clinical trial on the safety and efficacy of lobaplatin-based chemotherapy in advanced breast cancer
期刊论文
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 卷号: 14
作者:
Yan, Min
;
Yuan, Peng
;
Ouyang, Quchang
;
Cheng, Ying
;
Han, Guohui
;
Wang, Dewei
;
Ran, Li
;
Sun, Tao
;
Zhao, Da
;
Bai, Yuju
;
Yang, Shun'e
;
Wang, Xiaojia
;
Wu, Rong
;
Zeng, Xiaohua
;
Yao, Herui
;
Ji, Xuening
;
Jiang, Jun
;
Hu, Xiaohua
;
Lin, Haifeng
;
Zheng, Liping
;
Zhu, Zhitu
;
Ge, Wei
;
Yang, Junlan
;
Cui, Tongjian
;
Zhang, Xiaozhi
;
Lu, Fangyang
;
Li, Wenhui
;
Xu, Hongyan
;
Kang, Mafei
;
Gong, Ping
;
Zou, Liqun
;
Liu, Jiang
;
Zhang, Hongliang
;
Yu, Hao
;
Xu, Binghe
收藏
  |  
浏览/下载:52/0
  |  
提交时间:2022/12/23
breast cancer
chemotherapy
efficacy
lobaplatin
neoplasm metastasis
safety
Vanguard is a Glucose Deprivation-Responsive Long Non-Coding RNA Essential for Chromatin Remodeling-Reliant DNA Repair
期刊论文
ADVANCED SCIENCE, 2022
作者:
Zhang, Ben
;
Thorne, Rick Francis
;
Zhang, Pengfei
;
Wu, Mian
;
Liu, Lianxin
收藏
  |  
浏览/下载:43/0
  |  
提交时间:2022/12/23
genomic stability
HMGB1
long non-coding RNAs
PARP inhibitors
Vanguard
Apatinib combined with chemotherapy versus single chemotherapy in HER-2 negative advanced breast cancer: A randomized, controlled, open-label phase II study.
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:
Chen, Zhanhong
;
Wang, Xiaojia
;
Huang, Jian
;
Zheng, Yabing
;
Shao, Xiying
;
Cao, Wenming
;
Chen, Junqing
;
Ye, Weiwu
;
Ping, Huang
;
Li, Guangliang
;
Lei, Lei
;
Shi, Lei
;
Huang, Yuan
;
Zou, Weibin
;
Wang, Rong
;
Shen, Xia-Bo
;
Lou, Caijin
收藏
  |  
浏览/下载:33/0
  |  
提交时间:2022/12/23
Maintenance endocrine therapy prolonged progression-free survival of first-line chemotherapy with trastuzumab in advanced HR-positive, HER2-positive breast cancer patients.
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:
Shen, Xia-Bo
;
Wu, Jia-Yi
;
Chen, Ke-Yu
;
Fang, Zi-Ru
;
Li, Guang-Liang
;
Zou, Wei-Bin
;
Wang, Xiaojia
;
Shao, Xi-Ying
收藏
  |  
浏览/下载:32/0
  |  
提交时间:2022/12/23
Label-Free Detection and Translocation Dynamics Study of Single-Molecule Herceptin Using Solid-State Nanopores
期刊论文
ADVANCED MATERIALS TECHNOLOGIES, 2022
作者:
Hu, Rui
;
Lu, Wenlong
;
Wei, Guanghao
;
Nan, Hexin
;
Li, Juan
;
Zhao, Qing
收藏
  |  
浏览/下载:37/0
  |  
提交时间:2022/12/23
solid-state nanopore
single-molecule detection
protein dynamics
monoclonal antibody
protein unfolding
The characteristics and novel clinical implications of CD4+CXCR5+Foxp3+follicular regulatory T cells in breast cancer
期刊论文
ANNALS OF TRANSLATIONAL MEDICINE, 2021, 卷号: 9
作者:
Miao, Xianyuan
;
Guo, Qiusheng
;
Pan, Zhiwen
;
Xu, Xiaohong
;
Shao, Xiying
;
Wang, Xiaojia
收藏
  |  
浏览/下载:51/0
  |  
提交时间:2021/11/01
Breast cancer (BC)
follicular regulatory T cell (Tfr)
T-cell immunoglobulin mucin 3 (TIM-3)
Combined everolimus and endocrine therapy in advanced HR-positive, HER2-negative Chinese breast cancer patients: a retrospective study
期刊论文
ANNALS OF TRANSLATIONAL MEDICINE, 2021, 卷号: 9
作者:
Shen, Xia-Bo
;
Li, Guang-Liang
;
Zheng, Ya-Bing
;
Chen, Zhan-Hong
;
Cao, Wen-Ming
;
Wang, Xiao-Jia
;
Shao, Xi-Ying
收藏
  |  
浏览/下载:41/0
  |  
提交时间:2021/11/01
Advanced breast cancer (ABC)
aromatase inhibitors (AIs)
everolimus (EVE)
fulvestrant (FUL)
retrospective study
Phase I dose-escalation and dose-expansion trial of CDK4/6 inhibitor FCN-437c in Chinese female patients with ER+HER2-advanced breast cancer (ABC).
期刊论文
CANCER RESEARCH, 2021, 卷号: 81
作者:
Zhang, Jian
;
Wang, Xiaojia
;
Wang, Xian
;
Hui, Aimin
;
Wu, Zhuli
;
Tian, Ling
;
Xu, Changjiang
;
Yang, Yuchen
;
Zhang, Wenjing
;
Hu, Xichun
收藏
  |  
浏览/下载:47/0
  |  
提交时间:2021/11/01
Everolimus combined with endocrine therapy in advanced HR-positive, HER2-negative Chinese breast cancer patients: A retrospective study.
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:
Shen, Xia-Bo
;
Li, Guang-Liang
;
Zheng, Ya-Bing
;
Chen, Zhan-Hong
;
Cao, Wen-Ming
;
Shao, Xi-Ying
;
Wang, Xiao-Jia
收藏
  |  
浏览/下载:45/0
  |  
提交时间:2022/01/10